索引于
  • 打开 J 门
  • Genamics 期刊搜索
  • 引用因子
  • 宇宙IF
  • 西马戈
  • 乌尔里希的期刊目录
  • 电子期刊图书馆
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • 期刊摘要索引目录
  • OCLC-WorldCat
  • 普罗奎斯特传票
  • 学者指导
  • 虚拟生物学图书馆 (vifabio)
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 谷歌学术
分享此页面
期刊传单
Flyer image

抽象的

Generation and Characterization of IgY antibodies from Lohmann Brown Hens Immunized with Salmonella spp. for their Subsequent Application in Nanotherapy

Gordon G, Morán G, Ayala L, Seqqat R, Fernández R and Torres M

Salmonellosis is a common type of food poisoning caused by the Salmonella enterica bacterium. This disease is common in Ecuador and it is propagated through poultry. A new alternative for controlling the infection in humans and animals is through passive immunity. Consequently, specific antibodies can be developed as therapeutic agents based on biodegradable nanoparticles liposomes. Specific antibodies are produced by inoculation of hens with specific antigens, followed by retrieving the antibodies accumulated in yolk. The objective of this work was to purify specific IgY antibodies against Salmonella spp from Lohmann Brown hens. A group of hens was immunized with a pool of Salmonella entérica subsp entérica serovar Enteritidis and Salmonella enterica subsp entérica serovar Infantis. These two pools of bacteria were previously inactivated with a treatment (T1) by forlmaldehyde or with a treatment (T2) by heat. Lipids were removed using 0.1% pectin, the protein pelleted with ammonium sulfate (35% w/v) is re-suspended in PB buffer 0.025M pH 8. The Total IgY antibodies were purified by DEAE cellulose. The highest yield of total IgY was 5.5 mg IgY/mL yolk following the (T2) treatment at 63 days post-immunization. The characterization was performed with ELISA and MABA techniques and the immunoreactivity was evaluated by Western blot in total antisera and purified protein, hybridized with commercial anti-chicken antibodies from SIGMA. The heavy chain 67 kDa and the light chain 25 kDa were visualized. Such antibodies could able to ensure quick and immediate protection against several biotargets, the new IgY has potential for nanotherapy against Salmonelosis diseases.